Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Free Cash Flow Generation Index

Latest as of September 2025: -0.44x

Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Free Cash Flow Generation Index of -0.44x as of September 2025. Free cash flow of CN¥-9.33 Million represents 0% of operating cash flow (CN¥21.03 Million). Read Shanghai Yizhong Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

-0.44x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-9.33 Million
CNY

Operating Cash Flow

CN¥21.03 Million
CNY

Capital Expenditures

CN¥30.36 Million
CNY

Shanghai Yizhong Pharmaceutical Co Ltd Free Cash Flow Generation Index (2022–2024)

Historical FCF Generation Index trend for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Explore Shanghai Yizhong Pharmaceutical Co Ltd (688091) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)

Year-by-year Free Cash Flow Generation Index for Shanghai Yizhong Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Shanghai Yizhong Pharmaceutical Co Ltd.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -1.03x CN¥-40.60 Million CN¥39.44 Million CN¥80.04 Million ▼ -214.6%
2023 0.90x CN¥77.77 Million CN¥86.55 Million CN¥8.78 Million ▲ +32.9%
2022 0.68x CN¥74.90 Million CN¥110.78 Million CN¥35.88 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).